Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,030 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Regulatory Filings
2026-05-07 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is a regulatory requirement for shareholders to disclose when their voting rights in a company cross certain thresholds. This matches the definition of a 'Major Shareholding Notification' (MRQ).
2026-03-16 English
Results of General Meeting
Regulatory Filings
2026-03-03 English
Results of General Meeting and Board Changes
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Results of General Meeting and Board Changes'. It provides a detailed breakdown of voting results for specific resolutions (votes for, against, and withheld) and discusses changes to the Board of Directors. This aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). While it also mentions board changes, the primary purpose of the filing is the disclosure of the general meeting voting results.
2026-03-03 English
Results of General Meeting and Board Changes
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement from Syncona Limited regarding the 'Results of General Meeting and Board Changes'. It explicitly lists the voting results for resolutions passed at a general meeting, including vote counts and percentages, which aligns with the definition of a 'Declaration of Voting Results & Voting Rights Announcements' (DVA). While it also mentions board changes, the primary purpose of the filing is the disclosure of the shareholder meeting outcomes.
2026-03-03 English
Quell Clinical Updates
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement issued by Syncona Limited regarding clinical trial updates for its portfolio company, Quell Therapeutics. It details the initiation of a Phase I/II clinical trial and provides interim data on another asset. As this is a general regulatory announcement regarding company operations and portfolio updates that does not fit into specific categories like financial reports or shareholder voting, it is classified as a Regulatory Filing (RNS).
2026-03-03 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.